(VIANEWS) – Another day of trading has ended and here’s today’s list of stocks that have had significant trading activity in the US session.

The three biggest winners today are Sorrento Therapeutics, Meten EdtechX Education Group Ltd., and Fastly.

Rank	Financial Asset	Price	Change	Updated (EST)
1	Sorrento Therapeutics (SRNE)	0.26	56.11%	2023-02-16 15:30:47
2	Meten EdtechX Education Group Ltd. (METXW)	0.06	36.83%	2023-02-16 07:17:10
3	Fastly (FSLY)	16.25	17.12%	2023-02-16 15:52:52
4	Natera (NTRA)	49.30	16.44%	2023-02-16 15:46:18
5	West Pharmaceutical (WST)	319.51	14.45%	2023-02-16 15:58:28
6	Seattle Genetics (SGEN)	160.39	12.91%	2023-02-16 15:45:10
7	Magnite (MGNI)	13.27	12.27%	2023-02-16 07:42:19
8	Roku (ROKU)	70.58	11.17%	2023-02-16 15:49:12
9	10x Genomics (TXG)	51.33	10.94%	2023-02-16 15:49:48
10	Fomento Economico Mexicano S.A.B. de C.V. (FMX)	94.88	9.31%	2023-02-16 15:54:02

The three biggest losers today are Ringcentral, QuantumScape, and Shopify.

Rank	Financial Asset	Price	Change	Updated (EST)
1	Ringcentral (RNG)	37.23	-23.09%	2023-02-16 15:49:00
2	QuantumScape (QS)	9.74	-17.69%	2023-02-16 15:53:24
3	Shopify (SHOP)	44.89	-15.92%	2023-02-16 15:50:50
4	Upwork (UPWK)	11.87	-14.85%	2023-02-16 15:49:57
5	Boston Beer Company (SAM)	336.02	-14.48%	2023-02-16 15:49:16
6	Lion Group Holding Ltd. (LGHLW)	0.02	-14.29%	2023-02-16 01:07:09
7	Neoleukin Therapeutics (NLTX)	0.53	-10.03%	2023-02-16 15:06:08
8	Marathon (MARA)	7.20	-9.37%	2023-02-16 15:58:33
9	Kornit Digital Ltd. (KRNT)	24.05	-9.25%	2023-02-15 21:15:09
10	Kingsoft Cloud Holdings Limited (KC)	4.35	-8.42%	2023-02-15 21:06:11

Winners today

1. Sorrento Therapeutics (SRNE) – 56.11%

Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex. The company provides cancer therapeutic by leveraging its proprietary G-MAB antibody library and targeted delivery modalities, which include chimeric antigen receptor T-cell therapy (CAR-T), dimeric antigen receptor T-cell therapy, and antibody drug conjugate, as well as bispecific antibody approach; and Sofusa, a drug delivery technology that deliver biologic directly into the lymphatic system. Its clinical programs in development include anti-CD38 CAR-T therapy for the treatment of multiple myeloma, as well as for amyloidosis and graft versus host disease. The company develops resiniferatoxin, a non-opioid-based TRPV1 agonist neurotoxin for late stage cancer and osteoarthritis knee pain treatment; and ZTlido, a lidocaine delivery system for the treatment of postherpetic neuralgia. It engages in the development of SEMDEXA, an injectable viscous gel formulation, which is Phase III trial for the treatment of sciatica, a pathology of low back pain; SP-103, an investigational non-aqueous lidocaine topical system undergoing clinical development in chronic low back pain condition; and SP-104, a novel low-dose delayed-release naltrexone hydrochloride formulation for the treatment of fibromyalgia. It has collaboration with SmartPharm Therapeutics Inc. to develop gene-encoded antibody vaccine to protect against COVID-19; Celularity, Inc. for initiating Phase I/II clinical study, including up to 94 patients with COVID-19; Mount Sinai Health System to develop COVI-SHIELD, an antibody therapy targeting SARS-CoV-2 infection; and Mayo Clinic for Phase Ib pilot study using sofusa lymphatic drug delivery technology to deliver Ipilimumab in patient with melanoma. The company was founded in 2006 and is based in San Diego, California.

NASDAQ ended the session with Sorrento Therapeutics rising 56.11% to $0.26 on Thursday while NASDAQ fell 1.78% to $11,855.83.

Earnings Per Share

As for profitability, Sorrento Therapeutics has a trailing twelve months EPS of $-1.3.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -326.72%.

Volume

Today’s last reported volume for Sorrento Therapeutics is 239258000 which is 986.27% above its average volume of 22025600.

More news about Sorrento Therapeutics.

2. Meten EdtechX Education Group Ltd. (METXW) – 36.83%

NASDAQ ended the session with Meten EdtechX Education Group Ltd. jumping 36.83% to $0.06 on Thursday, after five sequential sessions in a row of losses. NASDAQ slid 1.78% to $11,855.83, after three successive sessions in a row of gains, on what was an all-around down trend trading session today.

Yearly Top and Bottom Value

Meten EdtechX Education Group Ltd.’s stock is valued at $0.06 at 16:32 EST, above its 52-week high of $0.06.

More news about Meten EdtechX Education Group Ltd..

3. Fastly (FSLY) – 17.12%

Fastly, Inc. operates an edge cloud platform for processing, serving, and securing its customer's applications in the United States, the Asia Pacific, Europe, and internationally. The edge cloud is a category of Infrastructure as a Service that enables developers to build, secure, and deliver digital experiences at the edge of the internet. It is a programmable platform designed for web and application delivery. The company offers Compute@Edge; developer hub that includes solution library patterns and recipes, API and language references, change logs, and Fastly Fiddle solutions; device detection and geolocation, edge dictionaries, edge access control lists, and edge authentication services; full site delivery services, such as dynamic site acceleration, origin shield, instant purge, surrogate keys, real-time logging and stats, cloud optimizer, programmatic control, edge databases, content compression, reliability, and modern protocols and performance services; and streaming solutions and services, including live streaming, media shield, and origin connect. It also provides edge security solutions, such as DDoS protection and cloud, edge web application firewall (WAF), transport layer security (TLS), platform TLS, and compliance services; unified web application and API protection solutions that includes runtime self-application protection, advanced rate limiting, API and ATO protection, account takeover protection, bot protection, and next generation WAF. In addition, the company offers edge applications, such as load balancers and image optimizers; video on demand; and managed edge delivery services. It serves customers operating in digital publishing, media and entertainment, technology, online retail, travel and hospitality, and financial services industries. The company was formerly known as SkyCache, Inc. and changed its name to Fastly, Inc. in May 2012. Fastly, Inc. was incorporated in 2011 and is headquartered in San Francisco, California.

NYSE ended the session with Fastly jumping 17.12% to $16.25 on Thursday while NYSE fell 0.75% to $15,895.20.

Earnings Per Share

As for profitability, Fastly has a trailing twelve months EPS of $-0.93.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.46%.

Yearly Top and Bottom Value

Fastly’s stock is valued at $16.25 at 16:32 EST, way below its 52-week high of $64.07 and way higher than its 52-week low of $9.50.

More news about Fastly.

4. Natera (NTRA) – 16.44%

Natera, Inc., a diagnostics company, develops and commercializes molecular testing services worldwide. It offers Panorama, a non-invasive prenatal test that screens for chromosomal abnormalities of a fetus with a blood draw from the mother, as well as twin pregnancies for zygosity; Vistara, a single-gene mutations screening test to identify single-gene disorder; Horizon carrier screening to determine carrier status for various genetic diseases; and Spectrum to analyze chromosomal anomalies or inherited genetic conditions during an in vitro fertilization cycle. The company also provides Anora miscarriage test products to analyze fetal chromosomes to understand the cause of miscarriage; and non-invasive paternity testing products to determine paternity by gestation using a blood draw from the pregnant mother and alleged father. In addition, it offers Constellation, a cloud-based software product that allows laboratory customers to gain access through the cloud to the company's algorithms and bioinformatics in order to validate and launch tests; Signatera, a circulating tumor DNA technology that screen for a generic set of mutations independent of an individual's tumor; and Prospera used to assess organ transplant rejection. The company offers products through its direct sales force, as well as through a network of approximately 100 laboratory and distribution partners. It has a partnership agreement with BGI Genomics Co., Ltd. to develop, manufacture, and commercialize NGS-based genetic testing assays; and Foundation Medicine, Inc. to develop and commercialize personalized circulating tumor DNA monitoring assays. The company was formerly known as Gene Security Network, Inc. and changed its name to Natera, Inc. in 2012. Natera, Inc. was founded in 2003 and is headquartered in San Carlos, California.

NASDAQ ended the session with Natera jumping 16.44% to $49.30 on Thursday, following the last session’s upward trend. NASDAQ fell 1.78% to $11,855.83, after three successive sessions in a row of gains, on what was an all-around down trend exchanging session today.

Earnings Per Share

As for profitability, Natera has a trailing twelve months EPS of $-2.84.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -97.41%.

Volume

Today’s last reported volume for Natera is 3060630 which is 118.52% above its average volume of 1400560.

Revenue Growth

Year-on-year quarterly revenue growth grew by 33.2%, now sitting on 776M for the twelve trailing months.

Moving Average

Natera’s value is way higher than its 50-day moving average of $41.21 and way higher than its 200-day moving average of $42.21.

More news about Natera.

5. West Pharmaceutical (WST) – 14.45%

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products. It serves pharmaceutical, diagnostic, and medical device companies. The company distributes its products through its sales force and distribution network, as well as contract sales agents and regional distributors. West Pharmaceutical Services, Inc. was incorporated in 1923 and is headquartered in Exton, Pennsylvania.

NYSE ended the session with West Pharmaceutical jumping 14.45% to $319.51 on Thursday while NYSE fell 0.75% to $15,895.20.

Earnings Per Share

As for profitability, West Pharmaceutical has a trailing twelve months EPS of $5.57.

PE Ratio

West Pharmaceutical has a trailing twelve months price to earnings ratio of 57.38. Meaning, the purchaser of the share is investing $57.38 for every dollar of annual earnings.

Sales Growth

West Pharmaceutical’s sales growth is 1.1% for the current quarter and 3.4% for the next.

Volume

Today’s last reported volume for West Pharmaceutical is 1437700 which is 121.33% above its average volume of 649568.

More news about West Pharmaceutical.

6. Seattle Genetics (SGEN) – 12.91%

Seagen Inc., a biotechnology company, develops and commercializes therapies for the treatment of cancer in the United States and internationally. The company offers ADCETRIS, an antibody-drug conjugate (ADC) for the treatment of patients with Hodgkin lymphoma or CD30-positive T-cell lymphomas; PADCEV, an ADC targeting Nectin-4 for the treatment of advanced or metastatic urothelial cancer; and TUKYSA, an oral small molecule tyrosine kinase inhibitor for the treatment of adult patients with advanced unresectable or metastatic HER2-positive breast cancer. It also develops TIVDAK for metastatic cervical cancer and other solid tumors; Ladiratuzumab Vedotin, an ADC targeting LIV-1 for metastatic breast cancer and solid tumors; Disitamab Vedotin, a novel HER2-targeted ADC; and SEA-CD40, SEA-TGT, SEA-BCMA, and SEA-CD70 for various cancer diseases. Seagen Inc. has collaboration agreements with Takeda Pharmaceutical Company Limited; Agensys, Inc.; Genmab A/S; Merck; and RemeGen, Co. Ltd. The company was formerly known as Seattle Genetics, Inc. and changed its name to Seagen Inc. in October 2020. Seagen Inc. was incorporated in 1997 and is headquartered in Bothell, Washington.

NASDAQ ended the session with Seattle Genetics rising 12.91% to $160.39 on Thursday, after three consecutive sessions in a row of gains. NASDAQ dropped 1.78% to $11,855.83, after three sequential sessions in a row of gains, on what was an all-around negative trend exchanging session today.

Earnings Per Share

As for profitability, Seattle Genetics has a trailing twelve months EPS of $3.58.

PE Ratio

Seattle Genetics has a trailing twelve months price to earnings ratio of 44.75. Meaning, the purchaser of the share is investing $44.75 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -21.27%.

Yearly Top and Bottom Value

Seattle Genetics’s stock is valued at $160.39 at 16:32 EST, way below its 52-week high of $183.00 and way above its 52-week low of $105.43.

More news about Seattle Genetics.

7. Magnite (MGNI) – 12.27%

Magnite, Inc. operates an independent sell-side advertising platform in the United States and internationally. The company's advertising platform enables publishers to monetize various screens and formats, including CTV, desktop display, video, audio, and mobile, as well as allows agencies and brands to access brand-safe ad inventory and execute advertising transactions. It markets its technology solutions to buyers and sellers through a sales teams that operate from various locations. The company was formerly known as The Rubicon Project, Inc. and changed name to Magnite, Inc. in July 2020. Magnite, Inc. was incorporated in 2007 and is headquartered in Los Angeles, California.

NASDAQ ended the session with Magnite jumping 12.27% to $13.27 on Thursday, following the last session’s upward trend. NASDAQ fell 1.78% to $11,855.83, after three consecutive sessions in a row of gains, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, Magnite has a trailing twelve months EPS of $0.05.

PE Ratio

Magnite has a trailing twelve months price to earnings ratio of 294.89. Meaning, the purchaser of the share is investing $294.89 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -11.08%.

Revenue Growth

Year-on-year quarterly revenue growth grew by 10.6%, now sitting on 562.96M for the twelve trailing months.

Sales Growth

Magnite’s sales growth is 9% for the present quarter and 7.7% for the next.

Volume

Today’s last reported volume for Magnite is 2811910 which is 68.8% above its average volume of 1665780.

More news about Magnite.

8. Roku (ROKU) – 11.17%

Roku, Inc., together with its subsidiaries, operates a TV streaming platform. The company operates in two segments, Platform and Player. Its platform allows users to discover and access various movies and TV episodes, as well as live TV, news sports, shows, and others. As of December 31, 2021, the company had 60.1 million active accounts. It also provides digital and video advertising, content distribution, subscription, and billing services, as well as other commerce transactions, and brand sponsorship and promotions; and manufactures, sells, and licenses smart TVs under the Roku TV name. In addition, the company offers streaming players, and audio products and accessories under the Roku brand name; and sells branded channel buttons on remote controls of streaming devices. It provides its products and services through retailers and distributors, as well as directly to customers through its website in the United States, Canada, the United Kingdom, France, Mexico, Brazil, Chile, Peru, North and South Americas, and Europe. Roku, Inc. was incorporated in 2002 and is headquartered in San Jose, California.

NASDAQ ended the session with Roku rising 11.17% to $70.58 on Thursday while NASDAQ slid 1.78% to $11,855.83.

Roku earnings: ROKU stock up 10% despite extreme growth in Q4 operating expensesStill Roku stock is returning near to overbought on the Relative Strength Index on the daily chart, so keep that in mind. , Prior communication of the advertising decline in Q4 had led Wall Street to forecast a much worse revenue picture, but an increase in platform revenue kept Roku flat overall with the fourth quarter of 2021.

Earnings Per Share

As for profitability, Roku has a trailing twelve months EPS of $-0.14.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -8.68%.

More news about Roku.

9. 10x Genomics (TXG) – 10.94%

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity on a cell-by-cell basis; single cell immune profiling for measuring the activity of immune cells and their targets; single cell Assay for Transposase Accessible Chromati (ATAC) for measuring epigenetics comprising the physical organization of DNA; and single cell multiome ATAC + gene expression for measuring the genetic activity and epigenetic programming in the same cells across tens of thousands of cells in a single experiment. The company also provides visium spatial gene expression solution for measuring spatial gene expression patterns across a single tissue sample or gene expression and protein co-detection when combined with immunofluorescence. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

NASDAQ ended the session with 10x Genomics rising 10.94% to $51.33 on Thursday while NASDAQ fell 1.78% to $11,855.83.

Earnings Per Share

As for profitability, 10x Genomics has a trailing twelve months EPS of $-4.17.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -18.17%.

Volatility

10x Genomics’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.96%, a positive 0.31%, and a positive 3.23%.

10x Genomics’s highest amplitude of average volatility was 3.50% (last week), 3.08% (last month), and 3.23% (last quarter).

Revenue Growth

Year-on-year quarterly revenue growth declined by 1.1%, now sitting on 497.93M for the twelve trailing months.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, 10x Genomics’s stock is considered to be oversold (<=20).

More news about 10x Genomics.

10. Fomento Economico Mexicano S.A.B. de C.V. (FMX) – 9.31%

Fomento Económico Mexicano, S.A.B. de C.V., through its subsidiaries, operates as a bottler of Coca-Cola trademark beverages. The company produces, markets, and distributes Coca-Cola trademark beverages in Mexico, Guatemala, Nicaragua, Costa Rica, Panama, Colombia, Venezuela, Brazil, Argentina, and Uruguay. It also operates small-box retail chain stores in Mexico, Colombia, Peru, Chile, and Brazil under the OXXO name; retail service stations for fuels, motor oils, lubricants, and car care products under the OXXO GAS name in Mexico; and drugstores in Chile, Colombia, Ecuador, and Mexico under the Cruz Verde, Fybeca, SanaSana, YZA, La Moderna, and Farmacon names. In addition, the company is involved in the production and distribution of chillers, commercial refrigeration equipment, plastic boxes, food processing, and preservation and weighing equipment; and provision of logistic transportation, distribution and maintenance, point-of-sale refrigeration, and plastics solutions, as well as distribution platform for cleaning products and consumables. As of December 31, 2021, it operated 20,431 OXXO stores; 3,652 drugstores; and 567 OXXO GAS service stations. Fomento Económico Mexicano, S.A.B. de C.V. was founded in 1890 and is based in Monterrey, Mexico.

NYSE ended the session with Fomento Economico Mexicano S.A.B. de C.V. jumping 9.31% to $94.88 on Thursday while NYSE fell 0.75% to $15,895.20.

Earnings Per Share

As for profitability, Fomento Economico Mexicano S.A.B. de C.V. has a trailing twelve months EPS of $-0.27.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 12.66%.

Volume

Today’s last reported volume for Fomento Economico Mexicano S.A.B. de C.V. is 3094550 which is 440.65% above its average volume of 572373.

Moving Average

Fomento Economico Mexicano S.A.B. de C.V.’s value is way higher than its 50-day moving average of $80.11 and way above its 200-day moving average of $70.93.

Sales Growth

Fomento Economico Mexicano S.A.B. de C.V.’s sales growth for the next quarter is 16.9%.

Volatility

Fomento Economico Mexicano S.A.B. de C.V.’s last week, last month’s, and last quarter’s current intraday variation average was a positive 0.23%, a negative 0.07%, and a positive 1.04%.

Fomento Economico Mexicano S.A.B. de C.V.’s highest amplitude of average volatility was 1.31% (last week), 1.06% (last month), and 1.04% (last quarter).

More news about Fomento Economico Mexicano S.A.B. de C.V..

Losers Today

1. Ringcentral (RNG) – -23.09%

RingCentral, Inc. provides software-as-a-service solutions that enable businesses to communicate, collaborate, and connect in North America. The company offers business cloud communications and contact center solutions based on its Message Video Phone? platform. Its products include RingCentral Office that provides communication and collaboration across various modes, including high-definition voice, video, SMS, messaging and collaboration, conferencing, online meetings, and fax; RingCentral Contact Center, a collaborative contact center solution that delivers omni-channel; and RingCentral Engage Digital, a digital customer engagement platform that allows enterprises to interact with their customers. The company's products also comprise RingCentral Engage Voice, a cloud-based outbound/blended customer engagement platform for midsize and enterprise companies; RingCentral Video, a video meeting service which includes our RCV video and team messaging capabilities and offers video and audio conferencing, file sharing, contact, task, and calendar management. In addition, it offers RingCentral Professional, a cloud based virtual telephone service that provides inbound call answering and management services for professionals; and RingCentral Fax that provides online fax capabilities. The company serves a range of industries, including financial services, education, healthcare, legal services, real estate, retail, technology, insurance, construction, hospitality, and state and local government, as well as others. It sells its products through a network of direct sales representatives, as well as sales agents, resellers, and channel partners. RingCentral, Inc. has strategic partnerships with Alcatel-Lucent Enterprise; and Vodafone Business. The company was incorporated in 1999 and is headquartered in Belmont, California.

NYSE ended the session with Ringcentral dropping 23.09% to $37.23 on Thursday, after five successive sessions in a row of gains. NYSE slid 0.75% to $15,895.20, after two sequential sessions in a row of losses, on what was a somewhat negative trend trading session today.

Earnings Per Share

As for profitability, Ringcentral has a trailing twelve months EPS of $-0.94.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Ringcentral’s stock is considered to be oversold (<=20).

Volatility

Ringcentral’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.96%, a positive 0.83%, and a positive 3.31%.

Ringcentral’s highest amplitude of average volatility was 3.39% (last week), 3.93% (last month), and 3.31% (last quarter).

Volume

Today’s last reported volume for Ringcentral is 12441700 which is 638.2% above its average volume of 1685380.

More news about Ringcentral.

2. QuantumScape (QS) – -17.69%

QuantumScape Corporation, a development stage company, focuses on the development and commercialization of solid-state lithium-metal batteries for electric vehicles and other applications. The company was founded in 2010 and is headquartered in San Jose, California.

NYSE ended the session with QuantumScape falling 17.69% to $9.74 on Thursday, after five consecutive sessions in a row of gains. NYSE slid 0.75% to $15,895.20, after two sequential sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, QuantumScape has a trailing twelve months EPS of $-3.85.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -4.32%.

Previous days news about QuantumScape

• : quantumscape stock drops 14% after narrower quarterly loss. According to MarketWatch on Wednesday, 15 February, "In a letter to shareholders, the company, which is developing a solid-state battery for electric vehicles, said that it hit important milestones in 2022 but must "continue to improve cell reliability as we move from prototype to product." QuantumScape lost $109 million, or 25 cents a share, in the fourth quarter, compared with a loss of $67 million, or 16 cents a share, in the year-ago quarter. "

More news about QuantumScape.

3. Shopify (SHOP) – -15.92%

Shopify Inc., a commerce company, provides a commerce platform and services in Canada, the United States, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. The company's platform enables merchants to displays, manages, markets, and sells its products through various sales channels, including web and mobile storefronts, physical retail locations, pop-up shops, social media storefronts, native mobile apps, buy buttons, and marketplaces; and enables to manage products and inventory, process orders and payments, fulfill and ship orders, new buyers and build customer relationships, source products, leverage analytics and reporting, manage cash, payments and transactions, and access financing. It also sells custom themes and apps, and registration of domain names; and merchant solutions, which include accepting payments, shipping and fulfillment, and securing working capital. The company was formerly known as Jaded Pixel Technologies Inc. and changed its name to Shopify Inc. in November 2011. Shopify Inc. was incorporated in 2004 and is headquartered in Ottawa, Canada.

NYSE ended the session with Shopify falling 15.92% to $44.89 on Thursday while NYSE dropped 0.75% to $15,895.20.

Shopify stock earnings: SHOP plunges 10% on GAAP earnings missBoth famed investor Stanley Druckenmiller and hedge fund Coatue Management exited their positions in Shopify stock during the fourth quarter, according to 13Fs filed with the Securities & Exchange Commission., A break below this region would entail Shopify stock retesting support from late December at $32.40.

Earnings Per Share

As for profitability, Shopify has a trailing twelve months EPS of $12.79.

PE Ratio

Shopify has a trailing twelve months price to earnings ratio of 3.51. Meaning, the purchaser of the share is investing $3.51 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -31.98%.

Sales Growth

Shopify’s sales growth is 19.5% for the current quarter and 19.5% for the next.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Shopify’s stock is considered to be oversold (<=20).

More news about Shopify.

4. Upwork (UPWK) – -14.85%

Upwork Inc., together with its subsidiaries, operates a work marketplace that connects businesses with various independent professionals and agencies in the United States, India, the Philippines, and internationally. The company's work marketplace provides access to talent with various skills across a range of categories, including sales and marketing, customer service, data science and analytics, design and creative, web, mobile, and software development. Its work marketplace also enables clients to streamline workflows, such as talent sourcing, outreach, and contracting. The company's work marketplace offers access to various functionalities for remote engagements with talent, including communication and collaboration, ability to receive talent invoices through their work marketplace, and payment protection. Its marketplace offerings include Upwork Basic, Upwork Plus, Upwork Enterprise, and Upwork Payroll, as well as managed and internet escrow agency services. The company was formerly known as Elance-oDesk, Inc. and changed its name to Upwork Inc. in May 2015. Upwork Inc. was incorporated in 2013 and is headquartered in San Francisco, California.

NASDAQ ended the session with Upwork falling 14.85% to $11.87 on Thursday, after five consecutive sessions in a row of gains. NASDAQ slid 1.78% to $11,855.83, after three successive sessions in a row of gains, on what was an all-around bearish trend trading session today.

Earnings Per Share

As for profitability, Upwork has a trailing twelve months EPS of $-0.19.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -37.82%.

Yearly Top and Bottom Value

Upwork’s stock is valued at $11.87 at 16:32 EST, way under its 52-week high of $29.92 and way above its 52-week low of $9.79.

Volatility

Upwork’s last week, last month’s, and last quarter’s current intraday variation average was a negative 1.21%, a positive 0.25%, and a positive 2.94%.

Upwork’s highest amplitude of average volatility was 3.77% (last week), 2.95% (last month), and 2.94% (last quarter).

More news about Upwork.

5. Boston Beer Company (SAM) – -14.48%

The Boston Beer Company, Inc. produces and sells alcohol beverages primarily in the United States. The company's flagship beer is Samuel Adams Boston Lager. It offers various beers, hard ciders, and hard seltzers under the Samuel Adams, Twisted Tea, Truly Hard Seltzer, Angry Orchard, Dogfish Head, Angel City, Coney Island, Concrete Beach brand names. The company markets and sells its products to a network of approximately 400 wholesalers in the United States, as well as international wholesalers, importers, or other agencies that in turn sell to retailers, such as grocery stores, club stores, convenience stores, liquor stores, bars, restaurants, stadiums, and other retail outlets. It also sells in products in Canada, Europe, Israel, Australia, New Zealand, the Caribbean, the Pacific Rim, Mexico, and Central and South America. The Boston Beer Company, Inc. was founded in 1984 and is based in Boston, Massachusetts.

NYSE ended the session with Boston Beer Company sliding 14.48% to $336.02 on Thursday, after five successive sessions in a row of gains. NYSE fell 0.75% to $15,895.20, after two consecutive sessions in a row of losses, on what was a somewhat down trend trading session today.

Earnings Per Share

As for profitability, Boston Beer Company has a trailing twelve months EPS of $19.29.

PE Ratio

Boston Beer Company has a trailing twelve months price to earnings ratio of 17.42. Meaning, the purchaser of the share is investing $17.42 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 2.56%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Boston Beer Company’s stock is considered to be oversold (<=20).

Volatility

Boston Beer Company’s last week, last month’s, and last quarter’s current intraday variation average was a negative 0.74%, a positive 0.13%, and a positive 1.74%.

Boston Beer Company’s highest amplitude of average volatility was 1.94% (last week), 2.45% (last month), and 1.74% (last quarter).

Yearly Top and Bottom Value

Boston Beer Company’s stock is valued at $336.02 at 16:32 EST, way below its 52-week high of $432.05 and way above its 52-week low of $287.00.

Revenue Growth

Year-on-year quarterly revenue growth grew by 6.2%, now sitting on 1.99B for the twelve trailing months.

More news about Boston Beer Company.

6. Lion Group Holding Ltd. (LGHLW) – -14.29%

NASDAQ ended the session with Lion Group Holding Ltd. sliding 14.29% to $0.02 on Thursday, after five consecutive sessions in a row of losses. NASDAQ fell 1.78% to $11,855.83, after three consecutive sessions in a row of gains, on what was an all-around bearish trend trading session today.

Yearly Top and Bottom Value

Lion Group Holding Ltd.’s stock is valued at $0.02 at 16:32 EST, way below its 52-week low of $0.02.

More news about Lion Group Holding Ltd..

7. Neoleukin Therapeutics (NLTX) – -10.03%

Neoleukin Therapeutics, Inc., a biopharmaceutical company, develops immunotherapies for cancer, inflammation, and autoimmunity disorders using protein design technology. The company's lead product candidate is NL-201, a de novo protein designed to mimic the therapeutic activity of the cytokines interleukin (IL)-2/IL-15 for the treatment of various types of cancer, including renal cell carcinoma and melanoma. The company was formerly known as Aquinox Pharmaceuticals, Inc. and changed its name to Neoleukin Therapeutics, Inc. in August 2019. Neoleukin Therapeutics, Inc. was founded in 2003 and is headquartered in Seattle, Washington.

NASDAQ ended the session with Neoleukin Therapeutics dropping 10.03% to $0.53 on Thursday while NASDAQ slid 1.78% to $11,855.83.

Earnings Per Share

As for profitability, Neoleukin Therapeutics has a trailing twelve months EPS of $-1.109.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -45.51%.

More news about Neoleukin Therapeutics.

8. Marathon (MARA) – -9.37%

Marathon Digital Holdings, Inc. operates as a digital asset technology company that mines cryptocurrencies with a focus on the blockchain ecosystem and the generation of digital assets in United States. As of December 31, 2021, it had approximately 8,115 bitcoins, which included the 4,794 bitcoins held in the investment fund. The company was formerly known as Marathon Patent Group, Inc. and changed its name to Marathon Digital Holdings, Inc. in February 2021. Marathon Digital Holdings, Inc. was incorporated in 2010 and is headquartered in Las Vegas, Nevada.

NASDAQ ended the session with Marathon dropping 9.37% to $7.20 on Thursday while NASDAQ fell 1.78% to $11,855.83.

Earnings Per Share

As for profitability, Marathon has a trailing twelve months EPS of $-0.13.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -34.72%.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, Marathon’s stock is considered to be oversold (<=20).

Growth Estimates Quarters

The company’s growth estimates for the present quarter and the next is a negative 59.1% and a negative 250%, respectively.

More news about Marathon.

9. Kornit Digital Ltd. (KRNT) – -9.25%

Kornit Digital Ltd. develops, designs, and markets digital printing solutions for the fashion, apparel, and home decor segments of printed textile industry worldwide. The company's solutions include digital printing systems, ink and other consumables, associated software, and value-added services. Its products and services include direct-to-garment printing systems from smaller industrial operators to mass producers; NeoPigment ink and other consumables; QuickP designer software; and maintenance and support, and professional services. The company serves decorators, online businesses, brand owners, and contract printers. Kornit Digital Ltd. was incorporated in 2002 and is headquartered in Rosh HaAyin, Israel.

NASDAQ ended the session with Kornit Digital Ltd. sliding 9.25% to $24.05 on Thursday while NASDAQ dropped 1.78% to $11,855.83.

Earnings Per Share

As for profitability, Kornit Digital Ltd. has a trailing twelve months EPS of $0.11.

PE Ratio

Kornit Digital Ltd. has a trailing twelve months price to earnings ratio of 218.64. Meaning, the purchaser of the share is investing $218.64 for every dollar of annual earnings.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -5.85%.

Moving Average

Kornit Digital Ltd.’s value is under its 50-day moving average of $24.16 and way under its 200-day moving average of $30.23.

Earnings Before Interest, Taxes, Depreciation, and Amortization

Kornit Digital Ltd.’s EBITDA is -48.29.

Volume

Today’s last reported volume for Kornit Digital Ltd. is 618123 which is 89.31% above its average volume of 326510.

Yearly Top and Bottom Value

Kornit Digital Ltd.’s stock is valued at $24.05 at 16:32 EST, way under its 52-week high of $98.74 and way above its 52-week low of $19.44.

More news about Kornit Digital Ltd..

10. Kingsoft Cloud Holdings Limited (KC) – -8.42%

Kingsoft Cloud Holdings Limited provides cloud services to businesses and organizations in China. The company offers public cloud services to customers in various verticals, including game, video, AI, e-commerce, education, and mobile internet; enterprise cloud services to customers in financial service, public service, and healthcare business, and others. It also provides IoT–smart living solutions. The company was incorporated in 2012 and is headquartered in Beijing, the People's Republic of China.

NASDAQ ended the session with Kingsoft Cloud Holdings Limited falling 8.42% to $4.35 on Thursday, after two consecutive sessions in a row of losses. NASDAQ fell 1.78% to $11,855.83, after three sequential sessions in a row of gains, on what was an all-around bearish trend exchanging session today.

Earnings Per Share

As for profitability, Kingsoft Cloud Holdings Limited has a trailing twelve months EPS of $-1.119.

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -23.68%.

Growth Estimates Quarters

The company’s growth estimates for the ongoing quarter and the next is 26.5% and 22.2%, respectively.

Sales Growth

Kingsoft Cloud Holdings Limited’s sales growth is negative 17.9% for the ongoing quarter and negative 21.3% for the next.

Yearly Top and Bottom Value

Kingsoft Cloud Holdings Limited’s stock is valued at $4.35 at 16:32 EST, way under its 52-week high of $8.13 and way above its 52-week low of $1.77.

Revenue Growth

Year-on-year quarterly revenue growth declined by 18.4%, now sitting on 8.71B for the twelve trailing months.

More news about Kingsoft Cloud Holdings Limited.

Stay up to date with our winners and losers daily report